Physician profile
John D Sutterlin
NPI 1780636423
$4,498.93
in general payments reported to CMS, 2019-2025
31 companies · $904 in 2025
The $904 reported for 2025 was more than what 84% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74.93 · 2020: $167 · 2021: $449 · 2022: $734 · 2023: $1,149 · 2024: $1,021 · 2025: $904.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,074.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,074.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $867.30 | 2021-2025 | Vraylar, Qulipta, Ubrelvy |
| Lilly USA, LLC | $551.54 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals Lp | $485.05 | 2020-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $437.75 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $265.71 | 2023-2025 | |
| Endologix LLC | $168.45 | 2023 | Afx2 Bifurcated Endograft System, Ovation Ix Iliac Stent Graft |
| Amgen INC. | $155.94 | 2022-2025 | Repatha, Krystexxa, Otezla |
| Exact Sciences Corporation | $151.16 | 2023-2025 | Cologuard Collection Kit |
| Esperion Therapeutics, INC. | $147.93 | 2020-2025 | Nexletol, Nexlizet |
| Boston Scientific Corporation | $125.08 | 2019-2024 | Wavewriter Alpha Prime 16, Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.56 | 2021-2024 | Jardiance, Synjardy |
| Biohaven Pharmaceutical Holding Company Ltd. | $121.03 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $109.98 | 2024-2025 | Rexulti, Nuedexta |
| Abbott Laboratories | $100.32 | 2021-2025 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $98.76 | 2019-2025 | Capvaxive, Gardasil 9, Gardasil |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $92.36 | 2019-2025 | Veozah |
| Corcept Therapeutics | $75.79 | 2025 | Korlym |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $53.51 | 2025 | Caplyta |
| Glaxosmithkline, LLC. | $47.43 | 2022-2023 | Shingrix |
| Ultragenyx Pharmaceutical INC. | $42.35 | 2022-2023 | |
| Amarin Pharma, INC. | $36.47 | 2020-2021 | |
| Vanda Pharmaceuticals INC. | $29.55 | 2025 | Fanapt, Hetlioz |
| Biohaven Pharmaceuticals, INC. | $27.51 | 2021 | |
| Janssen Pharmaceuticals, INC | $27.51 | 2020 | |
| Allergan, INC. | $25.72 | 2020 | |
| Dexcom, INC. | $24.13 | 2022 | |
| Organogenesis INC. | $23.92 | 2024 | Affinity |
| Shield Therapeutics INC | $22.38 | 2024 | |
| Edwards Lifesciences Corporation | $21.63 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Xeris Pharmaceuticals, INC. | $21.50 | 2023 | Gvoke Hypopen |
| Sonex Health, INC. | $17.61 | 2025 | Sx-One Microknife |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Sutterlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.